CD4 and systemic sclerosis: An increased level of basal activation was found in both SSc groups (vs. HC), which was significantly higher in the Th17 and CD4+ CXCR3−CCR6− T cells of the ACA vs. anti-Scl-70 SSc patients (Table 4).